Epithelial-Myoepithelial Carcinoma: Frequent Morphologic and Molecular Evidence of Preexisting Pleomorphic Adenoma, Common HRAS Mutations in PLAG1-intact and HMGA2-intact Cases, and Occasional TP53, FBXW7, and SMARCB1 Alterations in High-grade Cases
暂无分享,去创建一个
Simion I. Chiosea | Caitlyn A. Miller | R. Seethala | S. Chiosea | A. Agaimy | I. Fonseca | L. Thompson | A. Udager | S. El Hallani | Alyssa Luvison | D. Bell | A. Assaad
[1] R. West,et al. Recurrent rearrangements of the Myb/SANT-like DNA-binding domain containing 3 gene (MSANTD3) in salivary gland acinic cell carcinoma , 2017, PloS one.
[2] Simion I. Chiosea,et al. Subsets of salivary duct carcinoma defined by morphologic evidence of pleomorphic adenoma, PLAG1 or HMGA2 rearrangements, and common genetic alterations , 2016, Cancer.
[3] Yuri E Nikiforov,et al. A Multiplexed Amplicon Approach for Detecting Gene Fusions by Next-Generation Sequencing. , 2016, The Journal of molecular diagnostics : JMD.
[4] K. Ji,et al. How to Target Activated Ras Proteins: Direct Inhibition vs. Induced Mislocalization. , 2016, Mini reviews in medicinal chemistry.
[5] L. Wood,et al. Whole-Genome Sequencing of Salivary Gland Adenoid Cystic Carcinoma , 2016, Cancer Prevention Research.
[6] N. Popov,et al. Regulating Fbw7 on the road to cancer. , 2016, Seminars in cancer biology.
[7] Simion I. Chiosea,et al. Salivary Duct Carcinoma: The Predominance of Apocrine Morphology, Prevalence of Histologic Variants, and Androgen Receptor Expression , 2015, The American journal of surgical pathology.
[8] Simion I. Chiosea,et al. Salivary duct carcinoma and the concept of early carcinoma ex pleomorphic adenoma , 2014, Histopathology.
[9] A. Agaimy. The Expanding Family of SMARCB1(INI1)-deficient Neoplasia: Implications of Phenotypic, Biological, and Molecular Heterogeneity , 2014, Advances in anatomic pathology.
[10] Simion I. Chiosea,et al. Novel PRKD gene rearrangements and variant fusions in cribriform adenocarcinoma of salivary gland origin , 2014, Genes, chromosomes & cancer.
[11] Simion I. Chiosea,et al. HRAS Mutations in Epithelial–Myoepithelial Carcinoma , 2014, Head and Neck Pathology.
[12] P. Laurent-Puig,et al. Expression and mutational status of treatment-relevant targets and key oncogenes in 123 malignant salivary gland tumours. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.
[13] B. Perez-Ordonez,et al. An analysis of PLAG1 and HMGA2 rearrangements in salivary duct carcinoma and examination of the role of precursor lesions , 2013, Histopathology.
[14] G. Stenman. Fusion Oncogenes in Salivary Gland Tumors: Molecular and Clinical Consequences , 2013, Head and Neck Pathology.
[15] Glenn R Masson,et al. Oncogenic mutations mimic and enhance dynamic events in the natural activation of phosphoinositide 3-kinase p110α (PIK3CA) , 2012, Proceedings of the National Academy of Sciences.
[16] X. Chen,et al. Epithelial-myoepithelial carcinoma with high grade transformation. , 2012, International journal of oral and maxillofacial surgery.
[17] A. Bahrami,et al. PLAG1 Alteration in Carcinoma Ex Pleomorphic Adenoma: Immunohistochemical and Fluorescence In Situ Hybridization Studies of 22 Cases , 2012, Head and Neck Pathology.
[18] R. Gibbs,et al. Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1 , 2011, Science.
[19] C. Antonescu,et al. EWSR1‐ATF1 fusion is a novel and consistent finding in hyalinizing clear‐cell carcinoma of salivary gland , 2011, Genes, chromosomes & cancer.
[20] E. Boerwinkle,et al. dbNSFP: A Lightweight Database of Human Nonsynonymous SNPs and Their Functional Predictions , 2011, Human mutation.
[21] Julian Downward,et al. RAS Interaction with PI3K: More Than Just Another Effector Pathway. , 2011, Genes & cancer.
[22] B. Perez-Ordonez,et al. Mammary Analogue Secretory Carcinoma of Salivary Glands, Containing the ETV6-NTRK3 Fusion Gene: A Hitherto Undescribed Salivary Gland Tumor Entity , 2010, The American journal of surgical pathology.
[23] R. Seethala,et al. New variants of epithelial-myoepithelial carcinoma: oncocytic-sebaceous and apocrine. , 2009, Archives of pathology & laboratory medicine.
[24] G. Stamp,et al. Binding of Ras to Phosphoinositide 3-Kinase p110α Is Required for Ras- Driven Tumorigenesis in Mice , 2007, Cell.
[25] Marc-André Elsliger,et al. Rare cancer-specific mutations in PIK3CA show gain of function , 2007, Proceedings of the National Academy of Sciences.
[26] R. Seethala,et al. Epithelial-Myoepithelial Carcinoma: A Review of the Clinicopathologic Spectrum and Immunophenotypic Characteristics in 61 Tumors of the Salivary Glands and Upper Aerodigestive Tract , 2007, The American journal of surgical pathology.
[27] A. Russo,et al. TP53 and p16INK4A, but not H‐KI‐Ras, are involved in tumorigenesis and progression of pleomorphic adenomas , 2006, Journal of cellular physiology.
[28] G. Tonon,et al. t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway , 2003, Nature Genetics.
[29] K. Kashima,et al. Epithelial‐myoepithelial carcinoma harboring p53 mutation Note , 2001, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[30] R. Chetty. Intercalated duct hyperplasia: possible relationship to epithelial‐myoepithelial carcinoma and hybrid tumours of salivary gland , 2000, Histopathology.
[31] L. Alós,et al. High-grade carcinoma component in epithelial-myoepithelial carcinoma of salivary glands clinicopathological, immunohistochemical and flow-cytometric study of three cases , 1999, Virchows Archiv.
[32] L. Nielsen,et al. Histopathology of salivary and mammary gland tumors in transgenic mice expressing a human Ha-ras oncogene. , 1991, Cancer research.
[33] J. Batsakis,et al. Epithelial-myoepithelial carcinoma of intercalated duct origin. A clinicopathologic and ultrastructural assessment of sixteen cases. , 1982, Oral surgery, oral medicine, and oral pathology.
[34] Stephen Moore,et al. Assessing copy number alterations in targeted, amplicon-based next-generation sequencing data. , 2015, The Journal of molecular diagnostics : JMD.
[35] C. Antonescu,et al. Consistent PLAG1 and HMGA2 abnormalities distinguish carcinoma ex-pleomorphic adenoma from its de novo counterparts. , 2015, Human pathology.
[36] Somak Roy,et al. SeqReporter: automating next-generation sequencing result interpretation and reporting workflow in a clinical laboratory. , 2014, The Journal of molecular diagnostics : JMD.
[37] I. Fonseca,et al. Epithelial-myoepithelial carcinoma of the salivary glands. A study of 22 cases , 2005, Virchows Archiv A.
[38] F. Greene,et al. AJCC cancer staging handbook : from the AJCC cancer staging manual , 2002 .
[39] J. Haubrich,et al. Cytogenetic subtyping of 220 salivary gland pleomorphic adenomas: correlation to occurrence, histological subtype, and in vitro cellular behavior. , 1993, Cancer genetics and cytogenetics.
[40] K. Donath,et al. [Diagnosis and ultrastructure of the tubular carcinoma of salivary gland ducts. Epithelial-myoepithelial carcinoma of the intercalated ducts]. , 1972, Virchows Archiv. A, Pathology. Pathologische Anatomie.